BofA warns Fed risks policy mistake with early rate cuts
LONDON - ADOR Diagnostics, an associate company of BATM Advanced Communications Limited (LSE: BVC; TASE: BVC), has announced the appointment of the Rt. Hon Nadhim Zahawi as Chairman of its Advisory Board. The former British government official and established businessman is set to provide strategic guidance as ADOR advances towards the commercialization of its diagnostic solutions.
Zahawi, known for co-founding the market research firm YouGov and his political career, including roles as Chancellor of the Exchequer and Minister for COVID-19 Vaccine Deployment, brings a blend of business acumen and government experience to the position. His appointment comes at a time when ADOR is engaging in pre-clinical validation of its NATlab molecular biology platform at the Lazzaro Spallanzani National Institute for Infectious Diseases in Rome.
The successful completion of this validation phase is expected to lead to the initial sales of NATlab and the commencement of the regulatory process under the European Union In Vitro Diagnostic Medical (EPA:ALDMS) Device Regulation, aiming for eligibility for sale in the EU market.
Moti Nagar, CEO of BATM, expressed enthusiasm for Zahawi's joining, citing his experience as beneficial to ADOR's mission to revolutionize disease detection and management. Zahawi himself remarked on the transformative potential of health tech, emphasizing ADOR Diagnostics' role in improving health outcomes and reducing the burden on healthcare systems.
This strategic move by ADOR highlights the company's commitment to innovation in healthcare diagnostics, aiming to impact the way diseases are detected and managed. The information for this article is based on a press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.